Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2223-2026

LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. Recall

LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.

FDA recall Class I

Ongoing

FDA lists this Class I recall for LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2223-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
May 6, 2026
FDA report date
Jun 10, 2026
Quantity in commerce
32 systems
Distribution
See key details
FDA cause
Software design (manufacturing process)

What is being recalled?

LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.

Affected model & UDI checker

Search the exact identifiers published for Z-2223-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedLVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.Check source notice00811505030122
FDA code information

Product Code LVP-SW-0005. UDI-DI: 00811505030122. Software Version 5.10.2

View the original FDA recall notice

Why was this product recalled?

Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Fresenius Kabi USA, LLC take?

Consignees were notified on about 05/06/2026 via letter. Consignees were informed of the issue, risk associated, and instructed to keep the Ivenix pump plugged in at all times rather than rely on battery and if a "Battery Extremely Low" alarm occurs while on battery, immediately connect the pump to AC. For any transport of a patient on an affected pump, have a plan for AC access. For patients receiving critical or short half-life infusion therapies, ensure an RN accompanies the patient during transport. Consignees were also instructed to notify other users if applicable, notify customers if affected units were transferred or distributed, and post the provided Safety Tip Sheet, Battery Health Software Anomaly in the Ivenix Large Volume Pump (LVP) notice alongside this letter in all areas where affected pumps are stored and used. consignees were asked to complete and return the provided Customer Reply Form.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology